0563U Biofire Spotfire RT–PCR Reimbursement

CPT code 0563U designates a proprietary laboratory analysis for the Biofire® Spotfire® Respiratory/Sore Throat (R/ST) Panel by bioMérieux, a multiplex RT–PCR assay that detects 11 viruses and four bacteria from an upper respiratory specimen and reports each pathogen as positive or negative. As a PLA code tied to a single manufacturer’s test, 0563U matters nationally for laboratory billing, coding clarity, and payer coverage determinations for multiplex respiratory pathogen testing.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a national overview of coverage considerations and benchmarking for proprietary respiratory molecular testing, highlighting how payers approach PLA-coded assays compared with broader multiplex panels.

Readers will find concise clinical context for the assay, the typical sites of service (clinical and hospital laboratories), common billing modifiers where available, and what to expect in payer coverage language. The report summarizes payer coverage patterns, coding and billing implications of PLA designation, and operational considerations for lab services submitting 0563U. Data not provided in the input are noted as unavailable where applicable.

Billing Code Overview

CPT code 0563U is a Proprietary Laboratory Analyses (PLA) code that applies exclusively to the Biofire® Spotfire® Respiratory/Sore Throat (R/ST) Panel — Respiratory Menu from bioMérieux. The test uses reverse transcription polymerase chain reaction (RT–PCR) technology on an upper respiratory specimen to detect 11 viruses and four bacteria. Each pathogen included on the panel is reported as either positive or negative.

Service Type: Proprietary molecular diagnostic laboratory test (RT–PCR panel for respiratory pathogens)

Typical Site of Service: Clinical laboratory or hospital laboratory

Clinical Context

A patient presents to an outpatient clinic or urgent care center with acute upper respiratory symptoms such as fever, sore throat, cough, nasal congestion, and/or shortness of breath during respiratory virus season. The clinician performs a focused history and physical exam and obtains an upper respiratory specimen (e.g., nasopharyngeal swab or nasal swab) for molecular testing. The specimen is sent to the performing laboratory using the Biofire® Spotfire® Respiratory/Sore Throat (R/ST) Panel — Respiratory Menu from bioMérieux. The laboratory runs reverse transcription polymerase chain reaction (RT–PCR)–based testing that reports each of 11 viruses and four bacteria as positive or negative. Results are returned to the ordering clinician to guide patient counseling, antiviral or antibiotic decision-making, isolation and infection-control measures, and public health reporting as required. Typical sites of service include hospital laboratories, outpatient/ambulatory care clinics, urgent care centers, and independent commercial reference laboratories.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier (standard reporting)	Use when no special circumstance applies and the test is reported as performed per usual method.
`22`

Taxonomy Code	Specialty	Notes
207Q00000X	Allergy & Immunology	Clinicians ordering respiratory pathogen panels for diagnostic evaluation of infectious symptoms.
207L00000X	Infectious Disease	Specialists interpreting complex infectious disease testing and managing treatment.
207P00000X	Pathology & Laboratory Medicine	Clinical laboratory directors and pathologists overseeing molecular diagnostic testing.
208D00000X	Emergency Medicine	Emergency clinicians ordering rapid diagnostic panels in acute care settings.
208M00000X	Family Medicine	Primary care and urgent care clinicians who commonly order respiratory pathogen testing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J02.9`	Acute pharyngitis, unspecified	Sore throat is a common indication to order a respiratory/sore throat molecular panel to identify viral or bacterial causes.
`J06.9`	Acute upper respiratory infection, unspecified	Non-specific URI symptoms often prompt multiplex respiratory testing to identify causative pathogens.
`J10.1`	Influenza due to other identified influenza virus with other respiratory manifestations	Confirmatory molecular testing for influenza may be reported within the panel results.
`J12.9`	Viral pneumonia, unspecified	Assessment of viral etiologies of lower respiratory infection can be supported by multiplex RT–PCR panels.
`J20.9`	Acute bronchitis, unspecified	When bronchiolitis/bronchitis symptoms are present, panel testing can identify viral triggers guiding management.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`87070`	Microorganism antigen detection by immunoassay technique, multiple-step method; per specimen	May be performed in parallel when rapid antigen testing is used before or alongside molecular panel testing.
`87804`	Infectious agent antigen detection by immunoassay with direct optical observation, single step method; multiple pathogens	Rapid point-of-care antigen tests for respiratory pathogens that may be used prior to ordering comprehensive RT–PCR panels.
`87471`	Infectious agent detection by nucleic acid (DNA or RNA); Influenza, direct probe technique	Specific molecular influenza assays may be ordered separately or used to corroborate panel findings.
`87631`	Infectious agent detection by nucleic acid (DNA or RNA); SARS-CoV-2, amplified probe technique	SARS-CoV-2 testing is commonly ordered alone or in addition to multiplex respiratory panels depending on clinical and public health needs.
`99000`	Handling and/or conveyance of specimen for transfer from the office to a laboratory	Administrative/transport code used when specimens are collected in outpatient settings and shipped to an external reference lab for the Biofire® panel.

OpenPayer

Summary & Overview

CPT 0563U: Biofire Spotfire Respiratory/Sore Throat RT–PCR Panel